132 related articles for article (PubMed ID: 28804820)
41. Prolongation of prothrombin time in the presence of rivaroxaban: is this the only cause?
Sagheer S; McRae S
Intern Med J; 2017 Feb; 47(2):225-227. PubMed ID: 28201865
[TBL] [Abstract][Full Text] [Related]
42. Coagulation.
Chee YL
J R Coll Physicians Edinb; 2014; 44(1):42-5. PubMed ID: 24995447
[TBL] [Abstract][Full Text] [Related]
43. [Acquired bleeding disorders - diagnostic approach].
Klamroth R
Internist (Berl); 2014 May; 55(5):514-20. PubMed ID: 24715274
[TBL] [Abstract][Full Text] [Related]
44. [Fletcher factor, Fitzgerald factor].
Saito H
Nihon Rinsho; 2004 Dec; 62 Suppl 12():663-6. PubMed ID: 15658418
[No Abstract] [Full Text] [Related]
45. Assessing nonvitamin K antagonist oral anticoagulants (NOACs) in the laboratory.
Gosselin RC; Adcock DM
Int J Lab Hematol; 2015 May; 37 Suppl 1():46-51. PubMed ID: 25976960
[TBL] [Abstract][Full Text] [Related]
46. INR comparison between the CoaguChek Pro PT(N) and a standard laboratory method.
Khoschnewis S; Hannes FM; Tschopp M; Wuillemin WA
Thromb Res; 2004; 113(5):327-32. PubMed ID: 15183045
[TBL] [Abstract][Full Text] [Related]
47. The coagulation profile of preterm delivery.
Keren-Politansky A; Breizman T; Brenner B; Sarig G; Drugan A
Thromb Res; 2014 Apr; 133(4):585-9. PubMed ID: 24508451
[TBL] [Abstract][Full Text] [Related]
48. EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis.
Kuo KH; Khan S; Rand ML; Mian HS; Brnjac E; Sandercock LE; Akula I; Julien JP; Pai EF; Chesney AE
PLoS One; 2016; 11(3):e0149830. PubMed ID: 26934472
[TBL] [Abstract][Full Text] [Related]
49. [Mixing test for prolonged clotting time: clinical availability and problems].
Uchiba M; Ando Y
Rinsho Byori; 2009 Oct; 57(10):1004-12. PubMed ID: 19928499
[TBL] [Abstract][Full Text] [Related]
50. Measuring direct thrombin inhibitors with routine and dedicated coagulation assays: which assay is helpful?
Curvers J; van de Kerkhof D; Stroobants AK; van den Dool EJ; Scharnhorst V
Am J Clin Pathol; 2012 Oct; 138(4):551-8. PubMed ID: 23010710
[TBL] [Abstract][Full Text] [Related]
51. [Thrombin generation assays and their clinical application].
Kern A; Várnai K; Vásárhelyi B
Orv Hetil; 2014 Jun; 155(22):851-7. PubMed ID: 24860049
[TBL] [Abstract][Full Text] [Related]
52. Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both?
Karlsson O; Jeppsson A; Hellgren M
Int J Obstet Anesth; 2014 Feb; 23(1):10-7. PubMed ID: 24342222
[TBL] [Abstract][Full Text] [Related]
53. Coagulation disorders and inhibitors of coagulation in children from Mansoura, Egypt.
Abdelrazik N; Rashad H; Selim T; Tharwat L
Hematology; 2007 Aug; 12(4):309-14. PubMed ID: 17654057
[TBL] [Abstract][Full Text] [Related]
54. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
Chng WJ; Sum C; Kuperan P
Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
[TBL] [Abstract][Full Text] [Related]
55. Evaluation and performance characteristics of the Q Hemostasis Analyzer, an automated coagulation analyzer.
Toulon P; Fischer F; Appert-Flory A; Jambou D
Thromb Res; 2014 May; 133(5):927-35. PubMed ID: 24650798
[TBL] [Abstract][Full Text] [Related]
56. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674
[TBL] [Abstract][Full Text] [Related]
57. Should healthy children who will undergo minor surgery be screened for coagulation disorder?
Kang S; Yoon HS; Lee EH
Pediatr Hematol Oncol; 2016 May; 33(4):233-8. PubMed ID: 27166650
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic accuracy of silica clotting time method for lupus anticoagulant in a clinical population with various symptoms of antiphospholipid syndrome.
Averina M; Johannesen S; Brox J
Lupus; 2016 Apr; 25(4):418-22. PubMed ID: 26612052
[TBL] [Abstract][Full Text] [Related]
59. Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency.
Ashizawa M; Kimura S; Wada H; Sakamoto K; Sato M; Terasako K; Kikuchi M; Nakasone H; Okuda S; Kako S; Yamazaki R; Oshima K; Matsuura K; Ohmori T; Madoiwa S; Nishida J; Mimuro J; Tabei K; Sakata Y; Kanda Y
Hematology; 2013 Sep; 18(5):300-4. PubMed ID: 23683688
[TBL] [Abstract][Full Text] [Related]
60. Monitoring the new antithrombotic drugs.
Walenga JM; Hoppensteadt DA
Semin Thromb Hemost; 2004 Dec; 30(6):683-95. PubMed ID: 15630675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
